Chengdu Kanghua Bio-products Co., Ltd. announced its board's approval to apply for a comprehensive credit line of up to RMB 2.5 billion from banks. This is to meet operational needs and requires shareholder approval. The credit line will be valid from the 2025 annual general meeting to the 2026 annual general meeting and can be used cyclically.
Summary generated by AI · Always verify with source document
Chengdu Kanghua Bio-products Co., Ltd. Announcement on Applying for Comprehensive Credit Line from Banks for 2026
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, completeness, and that there are no false records, misleading statements, or major omissions in the information disclosed.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.